Journal of Hepatology
Volume 54, Issue 1 , Pages 41-47, January 2011

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients

  • Marie-Louise C. Vachon

      Affiliations

    • Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    • Corresponding Author InformationCorresponding author. Address: Mount Sinai School of Medicine, One, Gustave L. Levy Place, Box 1123, NY 10029, USA. Tel.: +1 212 659 8877; fax: +1 212 659 8377.
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Stephanie H. Factor

      Affiliations

    • Division of Infectious Diseases, Mount Sinai School of Medicine, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Andrea D. Branch

      Affiliations

    • Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Maria-Isabel Fiel

      Affiliations

    • Department of Pathology, Mount Sinai School of Medicine, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Maribel Rodriguez-Torres

      Affiliations

    • Fundacion de Investigacion de Diego, San Juan, PR, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Norbert Bräu

      Affiliations

    • Divisions of Infectious Diseases and Liver Diseases, Mount Sinai School of Medicine, NY, USA
    • Veterans Affairs Medical Center, Bronx, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Richard K. Sterling

      Affiliations

    • Division of Liver Diseases, Virginia Commonwealth University Health Systems, Richmond, VA, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Jihad Slim

      Affiliations

    • Division of Infectious Diseases, St-Michael’s Medical Center, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Andrew H. Talal

      Affiliations

    • Division of Gastroenterology and Hepatology and Center for the Study of Hepatitis C, Weill Cornell Medical College, NY, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.
    • ,
  • Douglas T. Dieterich

      Affiliations

    • Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    • Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    • ,
  • Mark S. Sulkowski

      Affiliations

    • Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MA, USA
    • On behalf of Hepatitis Resource Network (HRN)-004.

Received 19 February 2010; received in revised form 11 June 2010; accepted 16 June 2010. published online 31 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8278(10)00715-4

doi:10.1016/j.jhep.2010.06.025

Journal of Hepatology
Volume 54, Issue 1 , Pages 41-47, January 2011

Article Tools

* Image Usage & Resolution